These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 13985901)

  • 41. Paralytic poliomyelitis--United States, 1980-1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Jan; 46(4):79-83. PubMed ID: 9048844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication.
    Cáceres VM; Sutter RW
    Clin Infect Dis; 2001 Aug; 33(4):531-41. PubMed ID: 11462191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Excretion rates after Sabin oral vaccination against poliomyelitis in Tyrol].
    Bauer P
    Arch Hyg Bakteriol; 1968 Dec; 152(5):410-4. PubMed ID: 4313799
    [No Abstract]   [Full Text] [Related]  

  • 44. [Present status of poliomyelitis in the municipality of São Paulo].
    Barbosa V
    Rev Saude Publica; 1968 Jun; 2(1):68-80. PubMed ID: 5740990
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strains.
    Verdijk P; Rots NY; Bakker WA
    Expert Rev Vaccines; 2011 May; 10(5):635-44. PubMed ID: 21604984
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An Introduction to Poliovirus: Pathogenesis, Vaccination, and the Endgame for Global Eradication.
    Minor PD
    Methods Mol Biol; 2016; 1387():1-10. PubMed ID: 26983727
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effectiveness of different strategies of vaccine prophylaxis for poliomyelitis in the Ukraine].
    Moĭseieva HV; Zadorozhna VI
    Lik Sprava; 2002; (2):85-8. PubMed ID: 12073271
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Studies of the effect poliomyelitis live vaccine (Sabin) in small infants].
    Hussels H; Hennessen W
    Med Klin; 1966 Feb; 61(5):165-7. PubMed ID: 4293160
    [No Abstract]   [Full Text] [Related]  

  • 49. SAFETY OF SABIN ORAL POLIOVACCINE STRAINS; MASS IMMUNIZATION PROGRAM IN LOS ANGELES COUNTY, 1962-1963.
    WEHRLE PF; LEEDOM JM; PORTNOY B; PIERCE NF; COWPER HH
    JAMA; 1963 Nov; 186():821-6. PubMed ID: 14061062
    [No Abstract]   [Full Text] [Related]  

  • 50. [Epidemiology of poliomyelitis among the school population of Genoa after introduction of Sabin vaccination. Virological and serological studies during the period 1967-70].
    Vannucci A; Badolati G; Lombardo G; Vassallo M
    G Ig Med Prev; 1971; 12(1):60-8. PubMed ID: 4340481
    [No Abstract]   [Full Text] [Related]  

  • 51. [Virological studies during vaccination with Sabin vaccine].
    Congiu A; Scarpa B
    Boll Soc Ital Biol Sper; 1966 Aug; 42(15):1005-6. PubMed ID: 5969307
    [No Abstract]   [Full Text] [Related]  

  • 52. Poliomyelitis on Taiwan. II. Virological and serological surveys before and after mass Sabin vaccination.
    Hsu ST; Lin SY
    Taiwan Yi Xue Hui Za Zhi; 1970 Sep; 69(9):469-75. PubMed ID: 4320935
    [No Abstract]   [Full Text] [Related]  

  • 53. Commentary on the oral poliomyelitis vaccine (Sabin) -- associated cases of acute persisting spinal paralysis.
    Biberi-Moroeanu S; Muntiu A
    Arch Roum Pathol Exp Microbiol; 1978; 37(3-4):355-68. PubMed ID: 757664
    [No Abstract]   [Full Text] [Related]  

  • 54. Assessment of efficacy of a live oral poliovirus vaccine for virulent Sabin-like poliovirus 1 strains in Japan.
    Iwai M; Nakayama T; Matsuura K; Hasegawa S; Ando S; Obara M; Nagai Y; Yoshida H; Horie H
    Acta Virol; 2006; 50(2):139-43. PubMed ID: 16808333
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [On 22 cases of poliomyelitis observed in Rome after the introduction of vaccination with the Sabin method].
    Rocchi G; Andreoni G
    G Mal Infett Parassit; 1970 Jun; 22(6):385-7. PubMed ID: 5459591
    [No Abstract]   [Full Text] [Related]  

  • 56. [VACCINE-ASSOCIATED PARALYTIC POLIOMYELITIS IN RUSSIAN FEDERATION DURING THE PERIOD OF CHANGES IN VACCINATION SCHEDULE (2006-2013 yy.)].
    Ivanova OE; Eremeeva TP; Morozova NS; Shakaryan AK; Gmyl AP; Yakovenko ML; Korotkova EA; Chernjavskaja OP; Baykova OY; Silenova OV; Krasota AY; Krasnoproshina LI; Mustafina AN; Kozlovskaja LI
    Vopr Virusol; 2016; 61(1):9-15. PubMed ID: 27145594
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Vaccination of the newborn infant with oral Sabin type I antipoliomyelitic vaccine. Serological study].
    Banfi A; Vergara MI; Avendaño O; Borgońo JM; Greiber R; Solari G; Concha F
    Rev Chil Pediatr; 1974; 45(6):491-3. PubMed ID: 4467230
    [No Abstract]   [Full Text] [Related]  

  • 58. [Serological and epidemiological effects of Sabin oral vaccination against poliomyelitis in Tyrol].
    Bauer P
    Arch Hyg Bakteriol; 1968 Dec; 152(5):405-9. PubMed ID: 5741512
    [No Abstract]   [Full Text] [Related]  

  • 59. Paralytic poliomyelitis caused by a vaccine-derived polio virus in an antibody-deficient Argentinean child.
    Hidalgo S; García Erro M; Cisterna D; Freire MC
    Pediatr Infect Dis J; 2003 Jun; 22(6):570-2. PubMed ID: 12828159
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monitoring of poliovirus neutralizing antibodies in São Paulo State, Brazil.
    Luchs A; Cilli A; Russo DH; Costa FF; Carmona Rde C; Timenetsky Mdo C
    Trans R Soc Trop Med Hyg; 2010 Sep; 104(9):625-7. PubMed ID: 20708125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.